<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210072/" ref="ordinalpos=3622&amp;ncbi_uid=6855008&amp;link_uid=PMC4210072" image-link="/pmc/articles/PMC4210072/figure/jdi12225-fig-0001/" class="imagepopup">Figure 1.  From: Are both protein kinase A‐ and protein kinase C‐dependent pathways involved in glucagon‐like peptide‐1 action on pancreatic insulin secretion?. </a></div><br /><div class="p4l_captionBody">New concept of signaling pathway of Glucagon‐like peptide‐1 (GLP‐1). Nanomolar GLP‐1 bind to GLP‐1 receptor,and then activate the cyclic adenosine monophosphate–protein kinase A (PKA) pathway and exchange protein directly activated by cyclic adenosine monophosphate 2 (Epac 2), which requires elevation of cyclic adenosine monophosphate (classical pathway). Picomolar GLP‐1 activates protein kinase C (PKC) through the same GLP‐1 receptor (high affinity site) and opens the L‐type calcium channel (novel pathway; blue). AC, adenylate cyclase; PLC, phospholipase C.</div></div>